Commercialization Payments. As further consideration for the rights granted to Pfizer under this Agreement and the supply commitments under Article 7, Pfizer shall pay to Auxilium tiered payments (“Commercialization Payments”) at the following rates (the “Commercialization Rates”) based on aggregate annual Net Sales of Product in the Territory for all or any portion of the Pfizer Year falling within the Commercialization Term: For that portion of aggregate annual Net Sales less than [***] Dollars ($[***]) [***] percent ([***]%) For that portion of aggregate annual Net Sales equal to or greater than [***] Dollars ($[***]) but less than or equal to [***] Dollars ($[***]) [***] percent ([***]%) For that portion of aggregate annual Net Sales greater than [***] Dollars ($[***]) [***] percent ([***]%)
Appears in 2 contracts
Sources: Development, Commercialization and Supply Agreement (Auxilium Pharmaceuticals Inc), Development, Commercialization and Supply Agreement (Auxilium Pharmaceuticals Inc)